Description
Anti-A-Kinase Anchor Protein 14 AKAP14 Antibody
| Catalog number: | B2021148 |
| Lot number: | Batch Dependent |
| Expiration Date: | Batch dependent |
| Amount: | 100 uL |
| Molecular Weight or Concentration: | 22.815 kDa |
| Supplied as: | Liquid |
| Applications: | a molecular tool for various biochemical applications |
| Storage: | 20C |
| Keywords: | Anti-A-Kinase Anchor Protein 14 Antibody, AKAP14 Antibody, Anti-AKAP14 Antibody, AKAP14 Inhibitor, AKAP14 Targeting Antibody, Anti-AKAP14 Protein Antibody |
| Grade: | Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity>18 M-cm) and are filtered through 0.22 um. |
References
- Kahn, C. R., & Flier, J. S. (2000). Obesity and insulin resistance. *Journal of Clinical Investigation*, 106(4), 473-481.
- Houslay, M. D., & Milligan, G. (1997). Tailoring cAMP-signalling responses through isoform multiplicity. *Trends in Biochemical Sciences*, 22(6), 217-220.
- Kahn, B. B., & Flier, J. S. (2000). Obesity and insulin resistance. *Journal of Clinical Investigation*, 106(4), 473-481.
- Kahn, C. R., & Flier, J. S. (2000). Obesity and insulin resistance. *Journal of Clinical Investigation*, 106(4), 473-481.
- Houslay, M. D., & Milligan, G. (1997). Tailoring cAMP-signalling responses through isoform multiplicity. *Trends in Biochemical Sciences*, 22(6), 217-220.
- Kahn, B. B., & Flier, J. S. (2000). Obesity and insulin resistance. *Journal of Clinical Investigation*, 106(4), 473-481.
- Houslay, M. D., & Milligan, G. (1997). Tailoring cAMP-signalling responses through isoform multiplicity. *Trends in Biochemical Sciences*, 22(6), 217-220.
- Kahn, B. B., & Flier, J. S. (2000). Obesity and insulin resistance. *Journal of Clinical Investigation*, 106(4), 473-481.
- Houslay, M. D., & Milligan, G. (1997). Tailoring cAMP-signalling responses through isoform multiplicity. *Trends in Biochemical Sciences*, 22(6), 217-220.
- Kahn, B. B., & Flier, J. S. (2000). Obesity and insulin resistance. *Journal of Clinical Investigation*, 106(4), 473-481.
